 |
 |
PRESS RELEASE: Boston Life Sciences Readies Altropane Trials Boston Business Journal 12:06 PM EST Thursday April 1, 2004 Boston Life Sciences Inc. and the FDA have finalized an agreement as to how the company will conduct a new Phase III clinical trial for its radio-imaging agent Altropane. The agent is intended to help doctors differentiate among tremors caused by Parkinson's disease or other factors. Boston Life Sciences plans to enroll at least 500 people in 25 centers across the United States, split evenly between those who have Parkinsonian tremors and non-Parkinsonian tremors. Boston Life Sciences is developing treatments and diagnostic products for central nervous system diseases and cancer. SOURCE: Boston Business Journal, MA http://boston.bizjournals.com/boston/stories/2004/03/29/daily49.html?jst=b_ln_hl * * * ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn